-
Register Now
-
Registration for this event is currently not available. For more information, please email support or call the Special Services number listed below.
-
Download Materials
Special Services
If you require special assistance to attend this event, please email Nathalie Dietrich at Nathalie.Dietrich@uky.edu .
An Equal Opportunity University.
Speakers
Christopher Bositis, Michelle Collins-Ogle, Tyler Evans, Laura Fanucchi, Carl Fichtenbaum, Monica Gandhi, Roy Gulick, Marwan Haddad, Jason Halperin, Jennifer Havens, Moises Huaman Joo, Hermione Hurley, Emily Jones, Deidre Lafferty, Ben Lafferty, Christina Madison, Kristen Marks, Lucas Rojas, Alice Thornton, Victor Valcour, Jon Zibbell
Christopher Bositis, MD, AAHIVS
Clinical Director of the HIV and Viral Hepatitis programs
Greater Lawrence Family Health Center
Lawrence, Massachusetts
Dr. Chris Bositis works at the Greater Lawrence Family Health Center in Lawrence, MA, where he is clinical director of the HIV and viral hepatitis programs, and a core member of the Lawrence Family Medicine Residency faculty. He is a graduate of the Yale University School of Medicine, and did his family medicine residency at Brown University/Memorial Hospital of Rhode Island. As a family physician working with historically marginalized and underserved communities that have suffered disproportionately from the overlapping opioid and infectious disease syndemics, he is committed to implementing evidence-based approaches to reduce the burden of these diseases in the community and to providing holistic, compassionate care to individuals living with them. As such, he has played a key role in the development and implementation of novel programs at Greater Lawrence, including their community-based syringe service program; the mobile buprenorphine program for individuals experiencing homelessness; the inpatient HIV and addiction medicine consult services; and the HIV/viral hepatitis area of concentration, which prepares family medicine residents to join the shrinking HIV workforce.
Michelle Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Medical Director
Montefiore Adolescent and Youth Sexual-health Clinic (MAYS)
Associate Professor of Pediatrics
Pediatric Infectious Diseases
Children Hospital at Montefiore
Einstein College of Medicine.
Bronx, New York
Dr. Michelle Collins-Ogle is a Pediatric Infectious Disease and Adolescent Medicine attending. Dr. Ogle has committed the majority of her career to providing comprehensive medical care to infants, children, adolescents and adults living with HIV / AIDS. She provides comprehensive gender affirming care for transgender and nonbinary pediatric and adolescents including those with HIV. She also provides prevention, diagnosis and treatment of sexually transmitted infections including HIV in at- risk adolescents. Dr. Ogle is the Medical Director of the Montefiore Adolescent and Youth Sexual-health Clinic at Children’s Hospital at Montefiore in the Bronx.
Dr. Collins-Ogle is Vice-Chair of the Board of Directors for the American Academy of HIV Medicine, and Vice Chair of the Infectious Disease Society of America’s Committee for Inclusion Diversity and Equity. She is a member of the Ryan White Medical Provider’s Coalition Steering Committee and also proudly served as a member of the Presidential Advisory Council on HIV/AIDS during the Obama Administration.
Tyler Evans, MD, MS, MPH, AAHIVS, DTM&H, FIDSA
Chief Executive Officer & Co-Founder
Wellness and Equity Alliance
Scotts Valley, California
Tyler B. Evans, MD, MS, MPH, AAHIVS, DTM&H, FIDSA currently serves as the CEO and co-founder for Wellness Equity Alliance, a national group of population and public health experts committed to transforming public health care delivery to historically marginalized communities. During the COVID-19 response, Dr. Evans held a number of positions, including the 1st chief medical officer (CMO) for NYC overseeing all COVID-19 operations in 2020, the chief executive and medical officer (CEO/CMO) for Curative Medical Associates, administering >2 million doses in 10 states with a focus on health equity, as well as the deputy public health officer, chief of the COVID-19 vaccination branch at Marin County Health and Human Services Agency, and one of the operational leads for the COVID-19 vaccination rollout with the Association of Bay Area Health Officers (ABAHO). He has held other leadership positions focusing on homelessness, substance abuse and migrant health, as well as leading infectious disease divisions in a number of organizations across the US. With training in tropical medicine/infectious disease, internal medicine, public health/preventive medicine, and epidemiology, he has worked extensively with historically marginalized populations both in the US and abroad, including a number of international missions with Doctors without Borders, where he worked on pandemic responses (e.g. ebola, HIV), in addition to complex humanitarian emergencies. In terms of populations, his career has focused on health equity – primarily working with migrants, the LGBTQIA+, the homeless, and indigenous communities. He serves on several boards (eg HIVMA) and holds two faculty appointments at USC and UCSF. He lives in the Santa Cruz Mountains, CA with his wife and two babies.
Laura Fanucchi, MD, MPH
Associate Professor, Medicine
Division of Infectious Diseases
Center on Drug and Alcohol Research
University of Kentucky
Director, UK Addiction Consult and Education Services
Lexington, Kentucky
Dr. Laura Fanucchi is Associate Professor of Medicine in the Division of Infectious Diseases and the Center on Drug and Alcohol Research at the University of Kentucky. She received her MD and MPH from Emory University, and completed an Internal Medicine residency and Chief Residency at New York-Presbyterian Hospital / Weill Cornell. She is board-certified in Internal Medicine and Addiction Medicine and is Director of the UK Addiction Consult and Education Service. She also provides treatment for opioid use disorder in the UK Bluegrass Care Clinic and in the UK First Bridge Clinic. Dr. Fanucchi's research focus is in integrating evidence-based treatment of opioid use disorder in medically complex patient populations. She has presented regionally and nationally on the management of hospitalized patients with opioid use disorder, and provides training to physicians and other members of the healthcare team.
Carl Fichtenbaum, MD
Gregory W. Rouan, MD, Endowed Professor of Education in Internal Medicine
Associate Chairman of Medicine for Translational Research
Vice Chair for Clinical Research for Internal Medicine
University of Cincinnati Health
Cinicinnati, Ohio
Carl Fichtenbaum is Professor of Clinical Medicine and Associate Chairman at the Department of Medicine for Translational Research at the University of Cincinnati College of Medicine. Dr. Fichtenbaum earned his medical degree from the University of Missouri School of Medicine. He then completed his Internal Medicine Residency and Chief Resident year at Bridgeport Hospital/Yale University, his Infectious Diseases Fellowship at Washington University, and his AIDS Fellowship at Yale University.
Dr. Fichtenbaum’s research has focused on the clinical investigation of HIV infection. Over the past fifteen years his research has been focused on dyslipidemia and cardiovascular disease in persons with HIV infection. As a Principal Investigator of the AIDS Clinical Trials Group, he has led multiple key clinical trials pertaining to the health of people with HIV and produced numerous peer-reviewed publications including pioneering work on statin interactions with antiretroviral therapy.
Dr. Fichtenbaum is Vice-Chair of the REPRIEVE protocol and Chair of the Site Selection Committee.
Monica Gandhi, MD, MPH
Professor of Medicine
Associate Division Chief (Clinical Operations/ Education)
Division of HIV, Infectious Diseases, and Global Medicine
UCSF/ San Francisco General Hospital
San Francisco, California
Monica Gandhi MD, MPH is a Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the Director of the UCSF Center for AIDS Research (CFAR) and the Medical Director of the HIV Clinic ("Ward 86") at San Francisco General Hospital. She serves as the Associate Program Director of the ID fellowship at UCSF. Her research focuses on HIV treatment and prevention optimization, HIV and women, adherence measurement in HIV and TB, adherence interventions, and the interplay between COVID-19 and HIV. She served as the Co-Chair of the International AIDS Conference in San Francisco/Oakland in 2020 and has recently worked on COVID-19 mitigation and vaccination strategies, with a book on the COVID-19 pandemic (called “Endemic: A Post Pandemic Playbook”) from Mayo Clinic Press in 2023.
Roy Gulick, MD, MPH
Rochelle Belfer Professor of Medicine
Chief, Infectious Diseases
Weill Medical College of Cornell University Attending Physician
New York Presbyterian Hospital
New York, New York
Dr. Gulick is the Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Cornell Medicine, and Attending Physician at the New York Presbyterian Hospital in New York City. He is board certified in internal medicine and infectious diseases.
Dr. Gulick’s research interests include designing, conducting and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention and assess antiretroviral agents with new mechanisms of action. He currently serves as Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG) and the HIV Prevention Trials Network (HPTN), sponsored by the U.S. National Institutes of Health.
He also serves as the Co-Chair of the U.S. Department of Health and Human Services (DHHS) Panel on Clinical Practices for Treatment of HIV Infection, a Board Member of the International Antiviral Society-USA, and previously served as a Member and as Chair of the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) and as a Member and as Chair of the NIH Office of AIDS Research Advisory Committee (OARAC). He most recently serves as the Co-Chair of the NIH COVID-19 Treatment Guidelines Panel. He is a Member of the American Society of Clinical Investigation, the Association of American Physicians, International AIDS Society, and the Infectious Diseases Society of America, and has presented at national and international meetings and published widely.
Marwan Haddad, MD, MPH, AAHIVS
Medical Director of the Center for Key Populations
Community Health Center, Inc. (CHCI)
Middletown, Connecticut
Marwan Haddad is currently the Medical Director of the Center for Key Populations at Community Health Center, Inc. (CHCI), one of the largest federally qualified health centers in the nation. The Center for Key Populations is the first center of its kind focused on engaging populations who traditionally experience barriers to comprehensive and respectful care secondary to stigma and discrimination. The Center brings together under one roof healthcare, training, research, and advocacy for the LGB (Lesbian, Gay, Bisexual) and Transgender communities, people who use drugs, the homeless and those experiencing housing instability, and the recently incarcerated. The Center oversees the HIV, Hepatitis C (HCV), Substance Use and Medication Assisted Treatment (MAT), Healthcare for the Homeless, and Sexually Transmitted Diseases programs among others at CHCI. Dr. Haddad joined CHCI in July 2006.
He received his Bachelor of Arts degree from Harvard University and his medical degree from McGill University. He completed his family medicine residency at University of Toronto and obtained his Masters in Public Health from Johns Hopkins University. He is board certified in Family Medicine. He is certified by the American Academy of HIV Medicine as an HIV specialist. He was also the recipient of the 2011 Primary Care Leadership Award presented by the Connecticut Center for Primary Care and was named Physician Health Care Hero of 2018 by the Hartford Business Journal. Dr. Haddad is an Assistant Clinical Professor of Family Medicine at Quinnipiac University. He currently serves as Chair-Elect of the HIV Medicine Association (HIVMA).
Since January 2012, Dr. Haddad has led the CHCI Weitzman ECHO HIV, HCV, and MAT programs which expand the integration of these programs not only within CHCI but nationwide. This model of care utilizes didactic and case-based learning via video conferences with medical providers, offering ongoing support, consultation and guidance to aid in delivering care to the HIV, HCV, and opioid-using populations. Dr. Haddad also provides technical assistance support to other health centers in setting up and enhancing integrated MAT programs across the country. Moreover, he has taught and lectured at state and national conferences on HIV, HCV, MAT and substance use management, and integrated care. He has published research on the integration of MAT in community health centers examining both substance use as well as primary care outcomes. He also has and continues to serve internationally as a consultant on HIV, HCV, opioid use disorder, integrated care, and virtual distance learning in Lesotho, Ukraine, Uganda, Jamaica, and Malaysia.
Jason Halperin, MD, MPH
Clinician
Crescent Care
Assistant Professor, Medicine
Tulane University’s School of Medicine
New Orleans, Louisiana
Dr. Halperin earned an MPH from Columbia University in New York followed by and MD from the University of Vermont College of Medicine in Burlington, Vermont. He completed residency at the Tulane University Department of Internal Medicine in New Orleans. Following residency, Dr. Halperin completed an infectious diseases fellowship at New York University.
His areas of interest are HIV, Hepatitis C, and HIV prevention services such as PrEP.
Dr. Halperin strongly believes in the importance of clinical research and quality innovations. He is the principal investigator of two on-going clinical trials and oversees HIV quality work at CrescentCare including its nationally recognized Rapid Start program.
Dr. Halperin is also a member of the New Orleans Regional AIDS Planning Council.
Jennifer Havens, PhD, MPH
Professor, Behavioral Science
University of Kentucky College of Medicine
and Center on Drug and Alcohol Research
Lexington, Kentucky
Dr. Havens earned an MPH and a PhD in infectious disease epidemiology from the Johns Hopkins Bloomberg School of Public Health.
Her areas of expertise include the epidemiology of rural opioid and other substance use and the infectious complications of injection drug use, including HIV and hepatitis C.
Moises Huaman Joo, MD, MSc
Associate Professor, Medicine/Infectious Disease/Internal Medicine
University of Cincinnati College of Medicine
Cincinnati, Ohio
Moises A. Huaman, MD MSc is a physician trained in infectious diseases, immunology, and clinical epidemiology. He is Associate Professor of Medicine at the University of Cincinnati and serves as Medical Director for the Hamilton County Tuberculosis Control Program in Ohio. Dr. Huaman has experience conducting tuberculosis and HIV studies locally and internationally. His research focuses on the interplay between tuberculosis, HIV, and cardio-metabolic diseases. He is a former Scholar of the AIDS Clinical Trials Group (ACTG) Minority HIV Investigator Mentoring Program and CTSA KL2 Program. He currently serves as co-Principal Investigator for the University of Cincinnati Clinical Research Site.
Hermione Hurley, MD
Infectious Disease, Addiction Medicine Physician
Denver Health and Hospital Authority, Denver, Colorado
Assistant Professor of Medicine
University of Colorado, Aurora, Colorado
Denver, Colorado
Hermione Hurley is an Assistant Professor at University of Colorado, working as an Infectious Disease and Addiction Medicine physician at Denver Health. Her interest in combining care for ID and substance was prompted by observing poor health outcomes for people after release from incarceration back into the community. Her position is supported by both Psychiatry and Medicine enabling her to treat ID in methadone clinics, and provide medical care for substance use in the ID clinic for people living with HIV.
Emily Jones, JD
Senior Immigration Attorney
Kentucky Refugee Ministries
Lexington, Kentucky
Emily Jones began the immigration legal services office of Kentucky Refugee Ministries (KRM) in Lexington in December of 2013. As the Senior Immigration Attorney, Emily focuses on the practice of humanitarian and family based immigration law assisting immigrant clients with a variety of cases, including but not limited to applications for citizenship and legal permanent residence, family petitions (to bring family members to the United States), U-Visas, violence against women act (VAWA) petitions, and asylum. She is an adjunct professor at the University of Kentucky Rosenberg College of Law where she teaches immigration law in the Spring and supervises law students participating in the Kentucky Refugee Ministries Externship. During the fall semester, Emily taught pre-law classes to undergraduates in the Political Science Department at the University of Kentucky. She is an At Large Commissioner on the Mayor’s International Affairs Advisory Commission (MIAAC) in Lexington, Kentucky. Prior to joining KRM, Emily practiced in the area of foreclosure defense at Community Legal Aid in Worcester, Massachusetts.
Emily graduated from the University of Kentucky with a B.A. in Political Science and French and holds a law degree from the University of Kentucky Rosenberg College of Law.
Deidre Lafferty, MSSW, LCSW
Primary Therapist | Owner
Reclaim Life Mental Health Center
Albany, Oregon
Dee Lafferty, MSSW, LCSW has two decades of experience nurturing individuals towards wellness. She is passionately dedicated to helping individuals recover from Post Traumatic Stress Disorder and empowering each individual’s innate potential. Dee is the owner and operator of Inner Guidance Services Inc, a psilocybin service center located in Albany, Oregon and licensed by the Oregon Health Authority. Beyond her enriching work with psychedelic therapy, Dee is also the owner and supervising therapist at Reclaim Life Mental Health Center in Albany, Oregon. In addition to being a licensed psilocybin facilitator, and Licensed Clinical Social Worker, Dee is a certified Eye Movement Desensitization and Reprocessing therapist and Eye Movement Desensitization and Reprocessing International Association approved consultant. Dee is also a certified Intuitive Eating therapist. Before finding her home in the Pacific Northwest, Dee grew up in the Appalachian Mountains of southern West Virginia and eastern Kentucky. Dee earned her Master of Science in Social Work from the University of Louisville, Kent School of Social Work in 2008. In 2023 Dee completed the Certified Psychedelic Therapy Provider training program through the Integrative Psychiatry Institute in Boulder, Colorado. Dee has a wide range of experience, including community mental health, adult and child protective services, adult guardianship services, inpatient therapy at a private psychiatric hospital, serving as crisis director at a community mental health center, and working as an outpatient therapist for a non-profit agency. Dee is committed to creating safe spaces for the LGBTQIA+ community and making wellness accessible to everyone. When the day’s work is done, the joy of her family and the delightful company of her three malti-poos keep Dee grounded.
Ben Lafferty, MD
Program Director
Child & Adolescent Psychiatrist
Samaritan Albany General Hospital Behavioral Health - Pleasant View
Albany, Oregon
Benjamin R. Lafferty, MD is a WV native who earned his medical degree from West Virginia University School of Medicine in Morgantown, WV. He completed residency/fellowship training in general, child, and adolescent psychiatry at West Virginia University Hospitals, Chestnut Ridge Center. He has been an attending physician for Samaritan Health Services for 7 years. Dr. Lafferty has been the Program Director for the Child and Adolescent Psychiatry Fellowship program and is a faculty member of the Psychiatry Residency training program. Dr. Lafferty enjoys working with medical students, residents, and fellows, with a focus on rural, community-based psychiatric care. He is board-certified in both General and Child & Adolescent Psychiatry by the American Board of Psychiatry and Neurology. He is a Clinical Associate Professor of Psychiatry for the College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA.
Christina Madison, PharmD, FCCP, AAHIVP
Chief Pharmacist and Public Information Officer
Wellness Equity Alliance (WEA)
Scotts Valley, California
Christina Madison, PharmD, FCCP, AAHIVP is the Chief Pharmacist and Public Information Officer for Wellness Equity Alliance (WEA). She is an award-winning residency trained clinical pharmacist with 2 decades of professional pharmacy experience. She specializes in public health with a focus on infectious disease and gender-based health. Dr. Madison is a TedX speaker and has been featured in over 250+ on-air television appearances as a health care expert including being featured on Good Morning America (GMA-3- What You Need to Know). She was also a featured panelist at The White House COVID-19 What Works Summit in 2022. She is also an adjunct Associate Professor of Pharmacy Practice with Roseman University of Health Sciences (RU), College of Pharmacy. Dr. Madison is also a volunteer provider at Volunteers in Medicine of Southern Nevada where she provides communicable disease and immunization clinical services. She is involved with several community non-profits that are dedicated to the healthcare needs of the community.
Kristen Marks, MD
Assistant Professor, Medicine, Public Health
Weill Cornell Medical College
Cornell University
New York, New York
Dr. Marks received Internal Medicine residency and Infectious Diseases fellowship training at New York-Presbyterian Hospital (Cornell), where she focused her clinical training and research on HIV and hepatitis virus infections, and she completed Weill Cornell's Master's Degree in Clinical Investigation.
Her current research focuses on improving treatment outcomes in patients with HIV and hepatitis virus co-infections and includes studies of acute HCV as well as new treatment strategies for chronic HCV. She is co-investigator in the Cornell HIV/AIDS Clinical Trials Unit and Center for Study of Hepatitis C, where she conducts treatment studies related to HIV and HCV. She also sits on IDSA, AASLD, and IAS-USA’s joint guidelines panel for “Recommendations for testing, managing and treating hepatitis C”.
Lucas Rojas
International Director of Operations
FLUX
Los Angeles, California
Lucas Rojas (He/El/They/Elle) is a Latin transmasculine identified individual who works in Health Services, Clinical and Behavioral research, specifically with transgender/non-binary youth and young adults as well as in data analysis. They also serve as the International Director of Operations for FLUX aiming to raise the profile and of Trans and Gender Non-Conforming community. They serve on the community advisory boards of The Unique Woman’s Coalition, Project Q, NMAC, AAHIVM, GJLA. They have a background in Mathematics, Statistics, biomedical health and Community Based Research. They are a well-regarded skilled facilitator & speaker and has served as a health equity, research consultant for numerous organizations across the nation and globe.
Alice Thornton, MD
Professor of Medicine
University of Kentucky College of Medicine Chief of the Division of Infectious Diseases University of Kentucky Medical Center Lexington, Kentucky
Dr. Thornton completed her medical degree at Marshall University in Huntington, West Virginia.
She completed her residency at Wake Forest University School of Medicine in Internal Medicine. She then completed her fellowship training with the Division of Infectious Diseases at Indiana University Purdue University (IUPUI) where she studied the pathogenesis of chancroid. She was recruited to assist in the development of an Infectious Diseases Fellowship Program at the University of Kentucky in 1998.
Dr. Thornton has successfully acquired four HRSA funded grants – Ryan White Part B, C and D and the Local Performance Site grant of the Southeast AIDS Training and Education Center. She is the Bluegrass Care Clinic site PI for the NIH-funded REPRIEVE Study – Randomized Clinical Trial to Prevent Vascular Events in HIV.
Dr. Thornton is a clinical site visitor for Health Resources and Services Administration (HRSA), and also serves as a grant reviewer for HRSA, National Institutes of Health (NIH), and the Centers for Disease Control and Prevention (CDC). Dr. Thornton is on the Ryan White Medical Providers Coalition Steering Committee, and has served on the HIVMA Board of Directors. She is a Professor of Medicine in the University of Kentucky Department of Internal Medicine and Chief of the UK Division of Infectious Diseases.
Victor Valcour, MD, PhD
Professor of Medicine
Executive Director, GBHI
UCSF Memory and Aging Center
San Francisco, California
Dr. Valcour is a Professor of Medicine with a shared appointment in the Division of Geriatric Medicine and the Department of Neurology. His work crosses disciplines to research and care for cognitive disorders in aging populations and to understand brain injury in the setting of HIV among all ages, including funded pediatric HIV studies. His clinical work involves consultations for patients with cognitive disorders at the UCSF Memory and Aging Center.
While much of Dr. Valcour's research is completed at UCSF, he has a large international portfolio with many opportunities for junior investigators. Within Southeast Asia, he is Deputy Director of SEARCH/Thailand operating research in acute HIV (within days of infection), pediatric HIV, and markers of dementia in chronic HIV. In Africa, he has partnered with the US Military HIV Research Program to survey cognitive disorders among HIV-infected individuals in Nigeria, Uganda, Kenya, and Tanzania.
Dr. Valcour is broadly involved in mentoring individuals at all levels of training who are interested in clinical research related to cognitive disorders, particularly in association with HIV infection. He has extensive global health experience.
Dr. Valcour’s research interests have two major emphases. He is currently developing a research program that aims to understand optimal care strategies for elders who develop dementia. Nested within the Memory and Aging Center, the long-term goal of this program is to provide model care for elders with cognitive disorders.
Dr. Valcour is internationally recognized for research in cognitive disorders related to HIV. He currently operates 3 NIH R01 series grants within 3 novel cohorts: (1) a chronic HIV infected cohort followed since first initiation of cART; (2) an acute HIV cohort of individuals infected for less than one month at enrollment; (3) and a pediatric cohort in Thailand and Cambodia. He is the Deputy Director of SEARCH/Thailand (www.SEARCHThailand.org). He also operates the UCSF HIV Over 60 Cohort focused on understanding cognitive disorders in the older HIV population living in the San Francisco Bay area. New research will survey of cognitive disorders in HIV for individuals living in Uganda, Kenya, Tanzania and Nigeria.
Dr. Valcour is actively engaged in mentoring individuals wishing to become independent clinical researchers. His research portfolio provides a broad array of local and international projects that can serve as resources for mentored projects. Dr. Valcour serves as an Executive Committee member of the AIDS Research Institute (ARI).
Jon Zibbell, PhD
Senior Public Health Scientist, Behavioral Health Research Division
RTI International
Adjunct Professor
Center for the Study of Human Health, Anthropology
Emory University
Atlanta, Georgia
Dr. Jon Zibbell, PhD. is a senior scientist in the Center for Behavioral Health Epidemiology, Implementation & Evaluation Research at RTI International where he conducts behavioral epidemiological research on risk factors and health outcomes associated with the illicit drug use. Dr. Zibbell is a medical anthropologist with 20+ years of field experience conducting mixed methods research with people who inject drugs (PWID). He is PI of a National Institute on Drug Abuse (NIDA)-funded, Fentanyl Overdose Response and Community Engagement (FORCE) study in the proposed study sites in North Carolina. Dr. Zibbell is also multiple PI (MPI) for the NIH-funded fentanyl test strip (FTS) study conducted in Greensboro, NC, and Morgantown, WV. Before coming to RTI, Dr. Zibbell worked as a Centers for Disease Control and Prevention (CDC) health scientist in the Divisions of Viral Hepatitis and Unintentional Injury Prevention where he conducted epidemiological and surveillance research on viral hepatitis and drug overdose. As a CDC health scientist, Dr. Zibbell was the lead qualitative investigator for fentanyl outbreak investigations in Massachusetts and Ohio in 2016 and qualitative lead for CDC’s Scott County HIV outbreak investigation in Austin, IN. Dr. Zibbell was a member of the 2015 White House Heroin Task Force and helped the Obama Administration develop its heroin response strategy. He was also appointed to the CDC committee that developed HHS guidelines for the federal government’s funding of syringe service programs. In addition to research, Dr. Zibbell has conducted rapid ethnographic needs assessments for community-based harm reduction programs and continues to assist states and community organizations in developing evidence-based approaches to reduce morbidity and mortality associated with the HCV and overdose epidemics. Dr. Zibbell has published extensively on the negative health outcomes associated with substance use disorders and injection drug use and he holds a joint, adjunct appointment in the Center for the Study of Human Health and the Department of Anthropology at Emory University.
